Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ganten

Showing results (71-80 of 533) with videos related to

Pageof 54
Sort By:
Journal De Pharmacologie|January 1, 1985
The dual role of angiotensin and vasopressin as plasma hormones and neuropeptides in cardiovascular regulationD Ganten, T Unger, R E Lang
Proceedings of the National Academy of Sciences of the United States of America|January 4, 1994
Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropinM Sander, D Ganten, S H Mellon
Journal of Hypertension|June 1, 1987
Atrial natriuretic peptide: a new factor in blood pressure controlR E Lang, T Unger, D Ganten
Cardiovascular Research|October 9, 1998
Lessons from rat models of hypertension: from Goldblatt to genetic engineeringY M Pinto, M Paul, D Ganten
Cardiovascular Drugs and Therapy|February 1, 1991
The role of neuropeptides in cardiovascular regulationD Ganten, M Paul, R E Lang
Biomedica Biochimica Acta|January 1, 1984
Interactions between brain angiotensin and prostaglandins in ratsB A Schölkens, R Steinbach, D Ganten
Fortschritte Der Medizin|June 14, 1984
[The central nervous system, regulation of blood pressure and hypertension. Recent advances in the role of the central nervous system in the regulation of blood pressure]T Unger, D Ganten, R E Lang
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1987
Brain peptides and blood pressure controlD Ganten, T Unger, R E Lang
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1986
Dual peroxidase and colloidal gold-labeling study of angiotensin converting enzyme and angiotensin-like immunoreactivity in the rat subfornical organV M Pickel, J Chan, D Ganten
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Pharmacology of converting enzyme inhibitors: new aspectsT Unger, D Ganten, R E Lang
Pageof 54

Showing results (71-80 of 533) with videos related to

Sort By:
Pageof 54
Journal De Pharmacologie|January 1, 1985
The dual role of angiotensin and vasopressin as plasma hormones and neuropeptides in cardiovascular regulationD Ganten, T Unger, R E Lang
Proceedings of the National Academy of Sciences of the United States of America|January 4, 1994
Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropinM Sander, D Ganten, S H Mellon
Journal of Hypertension|June 1, 1987
Atrial natriuretic peptide: a new factor in blood pressure controlR E Lang, T Unger, D Ganten
Cardiovascular Research|October 9, 1998
Lessons from rat models of hypertension: from Goldblatt to genetic engineeringY M Pinto, M Paul, D Ganten
Cardiovascular Drugs and Therapy|February 1, 1991
The role of neuropeptides in cardiovascular regulationD Ganten, M Paul, R E Lang
Biomedica Biochimica Acta|January 1, 1984
Interactions between brain angiotensin and prostaglandins in ratsB A Schölkens, R Steinbach, D Ganten
Fortschritte Der Medizin|June 14, 1984
[The central nervous system, regulation of blood pressure and hypertension. Recent advances in the role of the central nervous system in the regulation of blood pressure]T Unger, D Ganten, R E Lang
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1987
Brain peptides and blood pressure controlD Ganten, T Unger, R E Lang
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1986
Dual peroxidase and colloidal gold-labeling study of angiotensin converting enzyme and angiotensin-like immunoreactivity in the rat subfornical organV M Pickel, J Chan, D Ganten
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Pharmacology of converting enzyme inhibitors: new aspectsT Unger, D Ganten, R E Lang
Pageof 54